MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
Insmed Incorporated (NASDAQ: INSM)*
Organization & Developments: Insmed
Parents
Insmed Incorporated (NASDAQ: INSM)*
Children
*Insmed is focused on the development of drugs to treat metabolic and endocrine-related diseases and disorders associated with in
2019: Looking Behind Insmed's Recent Revenue Beat_seekingalpha.com
2019: VA_65--Insmed Incorporated
2021: Insmed Incorporated: Some Rare Insider Buying Noted
2023: Insmed's Arikayce: A High Flyer With A Heavy Load
2024: Insmed Incorporated: Now Comes The Hard Part
2024: Insmed shares double as lung drug data convince Wall Street
2024: Insmed Stock More Than Doubled in Value Tuesday—Here’s Why
2024: Insmed: Brensocatib Propels Stock As Regulatory Milestones Approach
2024: Insmed: PAH Treatment Advancement With 2nd Half 2025 Top-Line Data
2025: Insmed: Priority Review For Brensocatib Cements (Limited) Upside Opportunity
2025:Insmed: Company Presses On With Further POC PAH Treatment Data
Jumps
Finance & Acquisitions: Insmed
Key People: Insmed